ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

Persistence of ctDNA in Patients with Breast Cancer During Neoadjuvant Treatment Is a Significant Predictor of Poor Tumor Response.

Qing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.